Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inari Medical, Inc. (NARI)
NASDAQ:NARI
Inari Medical (NARI) Stock Price & Analysis
298 Followers
NARI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$36.73 - $71.85
Previous Close$51.39
Volume531.29K
Average Volume (3M)929.63K
Market Cap
$2.99B
Enterprise Value$2.90B
Total Cash (Recent Filing)$115.45M
Total Debt (Recent Filing)$32.05M
Price to Earnings (P/E)―
Beta0.67
Next Earnings
Jul 31, 2024EPS Estimate
-$0.19Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.41
Shares Outstanding58,138,159
10 Day Avg. Volume688,394
30 Day Avg. Volume929,634
Standard Deviation0.14
R-Squared0.13
Alpha-0.00132
Financial Highlights & Ratios
Price to Book (P/B)26.83
Price to Sales (P/S)20.25
Price to Cash Flow (P/CF)54.60
P/FCF Ratio67.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.88
Enterprise Value/Gross Profit6.68
Enterprise Value/Ebitda195.42
Forecast
1Y Price Target
$59.17Price Target Upside15.14% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Inari Medical News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceNARI increased its revenue guidance from $580-$595MM to $592.5-$602.5MM, with the midpoint increasing by ~$10MM and moving from 19% to 21% for the year.
Growth PotentialNARI sees lots of runway ahead to continue growth in the US VTE market, which grew approximately 20%, driven by improving technology, clinical data, and commercial efforts.
Innovation And TechnologyNARI's innovation strategy is working with its robust expanding portfolio that includes 3rd/4th generation technologies in VTE and more 510(k) clearances in 2023 vs. any other cardio-focused companies.
Bears Say
Financial PerformanceShares have been under-pressure following recently announced CID, US Sales Head departure, and ongoing competition.
Legal IssuesInari sued Imperative Care/Truvic, alleging that Truvic’s Symphony Thrombectomy System infringes 8 patents relevant to Inari’s FlowTriever and ClotTriever.
Market CompetitionNARI has ceded share in both the PE and DVT markets, although the overall market continues to grow.
---
Ownership Overview
22.40% Insiders
40.41% Mutual Funds
25.51% Other Institutional Investors
11.69% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NARI FAQ
What was Inari Medical, Inc.’s price range in the past 12 months?
Inari Medical, Inc. lowest stock price was $36.73 and its highest was $71.85 in the past 12 months.
What is Inari Medical, Inc.’s market cap?
Currently, no data Available
When is Inari Medical, Inc.’s upcoming earnings report date?
Inari Medical, Inc.’s upcoming earnings report date is Jul 31, 2024 which is in 24 days.
How were Inari Medical, Inc.’s earnings last quarter?
Inari Medical, Inc. released its earnings results on Apr 30, 2024. The company reported -$0.221 earnings per share for the quarter, missing the consensus estimate of -$0.157 by -$0.064.
Is Inari Medical, Inc. overvalued?
According to Wall Street analysts Inari Medical, Inc.’s price is currently Undervalued.
Does Inari Medical, Inc. pay dividends?
Inari Medical, Inc. does not currently pay dividends.
What is Inari Medical, Inc.’s EPS estimate?
Inari Medical, Inc.’s EPS estimate is -$0.19.
How many shares outstanding does Inari Medical, Inc. have?
Inari Medical, Inc. has 58,138,160 shares outstanding.
What happened to Inari Medical, Inc.’s price movement after its last earnings report?
Inari Medical, Inc. reported an EPS of -$0.221 in its last earnings report, missing expectations of -$0.157. Following the earnings report the stock price went up 11.409%.
Which hedge fund is a major shareholder of Inari Medical, Inc.?
Among the largest hedge funds holding Inari Medical, Inc.’s share is Slate Path Capital LP. It holds Inari Medical, Inc.’s shares valued at 20M.
---
Inari Medical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$59.17 (15.14% Upside)
$59.17 (15.14% Upside)
Blogger Sentiment
Bullish
NARI Sentiment 71%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 18.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.8%
Last 30 Days ▼ 3.8%
Last 30 Days ▼ 3.8%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-6.80%
12-Months-Change
Fundamentals
Return on Equity
-5.41%
Trailing 12-Months
Asset Growth
30.65%
Trailing 12-Months
Company Description
Inari Medical, Inc.
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from venous diseases. Its product portfolio includes ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTreiver product is used for the treatment of pulmonary embolism. Geographically, the company has its presence across the United States.
---
NARI Company Deck
---
NARI Earnings Call
Q1 2024
0:00 / 0:00
---
NARI Revenue Breakdown
96.48% VTE
3.52% Emerging Therapies
---
NARI Stock 12 Month Forecast
Average Price Target
$59.17
▲(15.14% Upside)
Technical Analysis
Best Analysts Covering NARI
1 Year
1 Year Success Rate
8/18 ratings generated profit
1 Year Average Return
+0.49%
reiterated a buy rating 2 months ago
Copying William Plovanic's trades and holding each position for 1 Year would result in 44.44% of your transactions generating a profit, with an average return of +0.49% per trade.
---